Coherus Oncology, Inc.

Coherus Oncology, Inc.verified

CHRS

Price:

$1.23

Market Cap:

$142.57M

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, Anti-ILT4 monoclonal antibody ...[Read more]

Industry

Biotechnology

IPO Date

2014-11-06

Stock Exchange

NASDAQ

Ticker

CHRS

The Dividend Yield as of December 2025 (TTM) for Coherus Oncology, Inc. (CHRS) is 0%

According to Coherus Oncology, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Coherus Oncology, Inc. (CHRS) Historical Dividend Yield (quarterly & annually)

How has CHRS Dividend Yield performed in the past?

The mean historical Dividend Yield of Coherus Oncology, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CHRS's Dividend Yield was at its highest in in the December 2015 quarter at 0%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Coherus Oncology, Inc. (CHRS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Coherus Oncology, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20240%0%
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%

Coherus Oncology, Inc. (CHRS) Average Dividend Yield

How has CHRS Dividend Yield performed in the past?

The current Dividend Yield of Coherus Oncology, Inc. (CHRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Coherus Oncology, Inc. (CHRS) Dividend Yield vs. Peers

How is CHRS’s Dividend Yield compared to its peers?

Coherus Oncology, Inc.’s Dividend Yield is less than OmniAb, Inc. (0%), less than Invivyd, Inc. (0%), less than SELLAS Life Sciences Group, Inc. (0%), less than Codexis, Inc. (0%), less than Avalo Therapeutics, Inc. (0%), less than Protalix BioTherapeutics, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Insight Molecular Diagnostics Inc. (0%), less than Sangamo Therapeutics, Inc. (0%), less than Protara Therapeutics, Inc. (0%),

Build a custom stock screener for Coherus Oncology, Inc. (CHRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coherus Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coherus Oncology, Inc. (CHRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coherus Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Coherus Oncology, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Coherus Oncology, Inc. (CHRS)?

What is the highest Dividend Yield for Coherus Oncology, Inc. (CHRS)?

What is the 3-year average Dividend Yield for Coherus Oncology, Inc. (CHRS)?

What is the 5-year average Dividend Yield for Coherus Oncology, Inc. (CHRS)?

How does the current Dividend Yield for Coherus Oncology, Inc. (CHRS) compare to its historical average?